17 November 2025
Cancers | Feature Papers from the First Half of 2025 in the “Molecular Cancer Biology” Section
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2025 in the Section “Molecular Cancer Biology”, which are listed below:
1. “Immunotherapy in Prostate Cancer: From a “Cold” Tumor to a “Hot” Prospect”
by Whi-An Kwon and Jae Young Joung
Cancers 2025, 17(7), 1064; https://doi.org/10.3390/cancers17071064
Available online: https://www.mdpi.com/2072-6694/17/7/1064
2. “Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies”
by Nawar Maher, Samir Mouhssine, Bassam Francis Matti, Alaa Fadhil Alwan and Gianluca Gaidano
Cancers 2025, 17(5), 907; https://doi.org/10.3390/cancers17050907
Available online: https://www.mdpi.com/2072-6694/17/5/907
3. “Unlocking the Therapeutic Potential of Algae-Derived Compounds in Hematological Malignancies”
by Tamara Vujović, Tina Paradžik, Sanja Babić Brčić and Roberto Piva
Cancers 2025, 17(2), 318; https://doi.org/10.3390/cancers17020318
Available online: https://www.mdpi.com/2072-6694/17/2/318
4. “S-Adenosylmethionine: A Multifaceted Regulator in Cancer Pathogenesis and Therapy”
by David Fernández-Ramos, Fernando Lopitz-Otsoa, Shelly C. Lu and José M. Mato
Cancers 2025, 17(3), 535; https://doi.org/10.3390/cancers17030535
Available online: https://www.mdpi.com/2072-6694/17/3/535
5. “Oncogenic Mutations and the Tumor Microenvironment: Drivers of Non-Small Cell Lung Cancer Progression”
by Achilleas G. Mitrakas, Christos Kakouratos, Ioannis Lamprou, Erasmia Xanthopoulou and Michael I. Koukourakis
Cancers 2025, 17(5), 853; https://doi.org/10.3390/cancers17050853
Available online: https://www.mdpi.com/2072-6694/17/5/853
6. “Calreticulin—From the Endoplasmic Reticulum to the Plasma Membrane—Adventures of a Wandering Protein”
by Gillian C. Okura, Alamelu G. Bharadwaj and David M. Waisman
Cancers 2025, 17(2), 288; https://doi.org/10.3390/cancers17020288
Available online: https://www.mdpi.com/2072-6694/17/2/288
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office